Regulatory Briefs: CLIA Update; Product Reclassification; Thrombogenicity Workshop
This article was originally published in The Gray Sheet
Executive Summary
FDA provides a Clinical Laboratory Improvement Amendments administrative procedures guidance update. Absorbable lung biopsy plugs are reclassified. FDA will host a public workshop to discuss methods for thrombogenicity testing on April 14.